See how we’ve helped ambitious businesses achieve extraordinary outcomes.
This month's Featured CLIENT
Hear from Australian Biotechnologies CEO simon berry, about his success with the mark bouw group.
"Mark has provided business and grant advisory for Australian Biotechnologies and our US business, Origin Biologic since 2015. His deep dive strategies and R&D plans have significantly contributed to our continuous growth." - Simon Berry
Read The Full story below.
Read what our Ecosystem has to say
Australian Biotechnologies exists to enhance the lives of Australians through the lasting gift of allografts. As part of our vision, we required a strategy plan to ensure that our R&D program was the best in the space to meet our mission statement. In 2015, Mark Bouw Group was tasked with developing and implementing a R&D data management strategy. Initially, Mark Bouw Group implemented the strategic plan and has since worked closely with our R&D team and key executives, ensuring that all are well versed with our R&D activities and business plans whilst continuing to provide expert advice. An outcome of our R&D data management platform has been our success in achieving approved R&D activity status with the Australian Government’s Department of Industry, Science, Energy and Resources since 2015, with the Mark Bouw Group working closely with our internal team and registered Tax Agent at all steps across the data collection and reporting process. Additionally, Mark Bouw Group has assisted our organisation with offshore go-to-market analysis during 2017 & 2019, and a R&D data management strategy for our JV, Origin Biologics based in Nevada, USA. Mark Bouw Group has a world class strategy tool kit that continuously adds value to our organisation. We consider Mark Bouw Group as a core advisory partner.
"Mark has provided business and grant advisory for Australian Biotechnologies and our US business, Origin Biologic since 2015. His deep dive strategies and R&D plans have significantly contributed to our continuous growth."
- Simon Berry, CEO at Australian Biotechnologies Pty Ltd, Sydney AUS
Stanford University (USA)
Mark Bouw has been visiting Industry Fellow at the Graduate School of Business, Stanford University within the Stanford Ignite Program since 2017. The Ignite Program provides the business fundamentals and the hands-on experience needed to turn ideas into ventures in a four-week, full-time or eight-week, part-time program.
“Dear Mr. Bouw, on behalf of Stanford Graduate School of Business, I want to thank you for your contributions to Stanford Ignite, a certificate program that has run on the Stanford campus for the last ten years. The program has had an exceptional legacy of inspiring innovation and entrepreneurship in extraordinary individuals. Your help with the Ignite programs at Stanford and in London since 2017 has been invaluable. You continue to provide guidance and insights to program participants outside the classroom, which is essential in creating a strong supportive community of innovative future leaders. The educational mission of Stanford GSB is rooted in the molding of principled and purposeful leaders who have impact and ignite change for the better. Having partners like you that share their time, experience and insights, and that share our mission, is an essential component for making each program a success. Thank you!”
- Yossi Feinberg, The Adams Distinguished Professor of Management and Professor of Economics, Graduate School of Business, Stanford University.
Origin Biologics is re-inventing the Allograft Contract Manufacturing model to be more customer-centric, cost-effective and flexible. In 2014, the Nevada Donor Network and Australian Biotechnologies began to investigate how they could enhance the gift of tissue donation. Mark Bouw Group was tasked with developing and implementing a strategy plan with Australian Biotechnologies from ideation through to a reality of a partnership with Nevada Donor Network to build a state-of- the-art facility, whereby the Nevada Donor Network could honor their tissue donors and Australian Biotechnologies could bring tissue processing to the American community. As a result, Origin Biologics was formed. Their extensive experience in allograft processing, and the support of several tissue procurement organizations, will allow for the immediate processing of up to 100,000 allografts (1,600 donors per/annum), on completion of our new facility in Q4,2019.
"Mark Bouw Group provided core strategic advisory to bring our vision to life. Mark and his team continue to value add to the joint venture across our R&D platform, market growth and bringing their strong strategic took kit as required”
- Simon Berry, Exec Chairman at Origin Biologics LLC, Las Vegas USA
University of Sydney
Their excellence in research and teaching makes the University of Sydney one of the top universities in Australia, regularly ranked in the world’s top 50 universities and Australia's leading MBA and Global Executive MBA. Mark Bouw Group works closely with University of Sydney Business School as one of its business of choice for its Business Practicum unit of study. This unit is a semester long placement provided to postgraduate and undergraduate business students. Mark Bouw Group provides quality Work-Integrated Learning (WIL) experience to assist leading post and undergraduate business students build their critical thinking, problem-solving and employability skills, while at the same time encouraging them to create their own professional brand identity. Multiple projects across market analysis, social marketing strategy and business strategy are undertaken under the direction of key Mark Bouw Group executives and University of Sydney academics. Mark Bouw is a Distinction level Alumni of the University of Sydney, Global Executive-MBA, graduating class of 2014.
Q-FE has a strong personal commitment to undertaking R&D and new product development. Q-FE focuses on solving machinery engineering problems in the comprehensive property maintenance services specialising in electrical substation, building maintenance, road maintenance and vegetation clearing markets. To assist with our various R&D projects, Mark Bouw Group was contracted and subsequently provided us with a deep understanding of the intricacies of R&D, how to put a R&D program into place, assisted us with our presentations to the relevant government departments for grant approvals. Mark Bouw Group is in contact with us on a regular basis to ensure that we are on track with our concepts and that we are compliant with tracking of information and associated R&D projects costs. We have found Mark Bouw Group to be knowledgeable, completely professional and highly ethical in their business conduct. They have shown a profound interest in our new business concepts and have demonstrated an excellent understanding of what we are trying to accomplish. Mark Bouw Group has certainly made the R&D process much easier for us to implement within our business. I am also pleased with our success in achieving approved R&D activity status with the Australian Government, Department of Industry, Science, Energy and Resources.
"Mark and his team have been our advisors, helping us to chart the innovation strategy landscape. With a 100% success rate, they keep our R&D strategy on track."
- Graham Laycock, Managing Director, Q-FE
“TJM” is the parent company of The Jolly Miller Café, I Pantry, Jolly Care and Fig Food Co companies. In 2014, TJM was running eight Jolly Miller Cafes across Melbourne with 50 staff and we wanted to grow. Mark Bouw Group was engaged to provide its strategic lens to our business and assist us with a strategic business plan through to 2020. The results of that plan speak today. The Jolly Miller Café chain with 13 sites, acquisition of Fig Food Co in 2018, expansion of our Sunshine West food production facility with leading innovative technology servicing over 400 food outlets daily, acquisition of Houghnuts food brand, development of IPantry-a full B2C daily pantry and fresh food e-commerce platform and, launch of the consumer healthcare products range-Jolly Care. Today we have nearly 400 team members and have 4 X our business since 2014. Mark Bouw Group has worked with us in the implementation of the strategy and has been there as much, or as little as we need them.
"They are pro-active in our business development, take the time to regularly keep abreast of our industry and most importantly, care about our business. We are now working with Mark Bouw Group as we prepare for the next five years of growth."
- Simon Barbar, CEO at TJM Group Holdings
Check out our services
Australian Entity Operations
We provide turnkey solutions for setting up your business in Australia. Learn how to get started today.DISCOVER
Strategies to Grow business
We have proven results working with businesses on their path to strategic & sustainable true economic profit. DISCOVER
Facilitate Government Grants
We formulate your innovation strategy that brings new products and services to market.DISCOVER
Are you ready to do business?
We offer a no obligation one hour consult.
Contact us if you’re ready to grow your business